Smith & Nephew to host Capital Markets Event on 10 November
21 October 2015
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that it will be holding a Capital Markets Event for institutional investors and analysts from 1.00pm GMT on 10 November 2015 in London, UK.
The event will provide insights into the Advanced Wound Management franchises and will be hosted by Olivier Bohuon, Chief Executive Officer, with presentations from senior leaders of the Company's Advanced Wound Management franchises.
Institutional investors or analysts wishing to attend should register on the Smith & Nephew corporate website:
www.smith-nephew.com/capitalmarketsevent/
Additionally, the presentations will be webcast live from 1:30pm GMT (8.30am EST) and archived after the event.
- ends -
Investors / Analysts
Ingeborg Øie
Smith & Nephew |
+44 (0) 20 7960 2285 |
Media
Charles Reynolds
Smith & Nephew |
+44 (0) 20 7401 7646 |
Debbie Scott / Matthew Cole
FTI Strategic Consulting |
+44 (0) 20 3727 1000 |
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to supporting healthcare professionals in their daily efforts to improve the lives of their patients. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries. Annual sales in 2014 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.
◊ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.
